CD38 and Miyoshi myopathy: IMiDs are able to induce NK‐cell activation, and lenalidomide and pomalidomide also upregulate CD38 on MM cells, resulting in the synergistic enhancement of the cytotoxic effects of CD38 antibodies.42, 162, 163, 164, 165